581 Results for "

AP

" in MedChemExpress (MCE) Product Catalog:
Products (581)

581 Results for "AP" in MCE Product Catalog:

657
657 Publications Verification
Cat. No.: HY-10256A
CAS No.: 869185-85-3
Purity:  99.37%
Synonyms: SB 203580 hydrochloride; RWJ 64809 hydrochloride
Adezmapimod (SB 203580; RWJ 64809) hydrochloride is a selective and ATP-competitive p38 MAPK inhibitor with IC50s of 50 nM and 500 nM for SAPK2a/p38 and SAPK2b/p38β2, respectively. Adezmapimod hydrochloride inhibits LCK, GSK3β and PKBα with IC50s of 100-500-fold higher than that for SAPK2a/p38. Adezmapimod hydrochloride does not disrupt JNK activity and is an autophagy and mitophagy activator .
loading...
    loading...
657
657 Publications Verification
Cat. No.: HY-10256
CAS No.: 152121-47-6
Purity:  99.92%
Synonyms: SB 203580; RWJ 64809
Adezmapimod (SB 203580) is a selective and ATP-competitive p38 MAPK inhibitor with IC50s of 50 nM and 500 nM for SAPK2a/p38 and SAPK2b/p38β2, respectively. Adezmapimod inhibits LCK, GSK3β and PKBα with IC50s of 100-500-fold higher than that for SAPK2a/p38. Adezmapimod can inhibit p38 MAPK and lead to the inhibition of downstream HSP27 phosphorylation. Adezmapimod does not disrupt JNK activity and is an autophagy and mitophagy activator .
loading...
    loading...
113
113 Cited Publications
Cat. No.: HY-12270
CAS No.: 530141-72-1
Purity:  99.03%
Target:  

AP-1 MMP

T-5224 is a transcription factor c-Fos/activator protein (AP)-1 inhibitor with anti-inflammatory effects, which specifically inhibits the DNA binding activity of c-Fos/c-Jun without affecting other transcription factors. T-5224 inhibits the IL-1β-induced up-regulation of Mmp-3, Mmp-13 and Adamts-5 transcription .
loading...
    loading...
61
61 Cited Publications
Cat. No.: HY-16046
CAS No.: 195514-63-7
Synonyms: AP1903
Target:  

FKBP Apoptosis

Research Areas:  

Cancer

Rimiducid (AP1903) is a dimerizer agent that acts by cross-linking the FKBP domains. Rimiducid (AP1903) dimerizes the Caspase 9 suicide switch and rapidly induces apoptosis.
loading...
    loading...
59
59 Cited Publications
Cat. No.: HY-12047
CAS No.: 943319-70-8
Purity:  99.67%
Synonyms: AP24534
Ponatinib (AP24534) is an orally active multi-targeted kinase inhibitor with IC50s of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM, and 5.4 nM for Abl, PDGFRα, VEGFR2, FGFR1, and Src, respectively .
loading...
    loading...
59
59 Cited Publications
Cat. No.: HY-108766
CAS No.: 1114544-31-8
Purity:  99.76%
Synonyms: AP24534 hydrochloride
Research Areas:  

Infection Cancer

Ponatinib hydrochloride (AP24534 hydrochloride) is a hydrochloride of ponatinib. Ponatinib is an orally active multi-targeted kinase inhibitor with IC50s of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM, and 5.4 nM for Abl, PDGFRα, VEGFR2, FGFR1, and Src, respectively .
loading...
    loading...
55
55 Cited Publications
Cat. No.: HY-13992
CAS No.: 195514-80-8
Purity:  99.85%
Synonyms: B/B Homodimerizer
Target:  

FKBP

Research Areas:  

Metabolic Disease

AP20187 (B/B Homodimerizer) is a cell-permeable ligand used to dimerize FK506-binding protein (FKBP) fusion proteins and initiate biological signaling cascades and gene expression or disrupt protein-protein interactions.
loading...
    loading...
41
41 Cited Publications
Cat. No.: HY-100714A
CAS No.: 79055-68-8
Purity:  99.94%
Synonyms: D-APV; D-2-Amino-5-phosphonovaleric acid
Target:  

iGluR

Research Areas:  

Neurological Disease

D-AP5 (D-APV) is a selective and competitive NMDA receptor antagonist with a Kd of 1.4 μM. D-AP5 (D-APV) inhibits the glutamate binding site of NMDA receptors .
loading...
    loading...
32
32 Cited Publications
Cat. No.: HY-12857
CAS No.: 1197953-54-0
Purity:  99.98%
Synonyms: AP-26113
Research Areas:  

Cancer

Brigatinib (AP-26113) is a highly potent, selective and orally active ALK inhibitor, with an IC50 of 0.6 nM. Brigatinib can be used for research of NSCLC .
loading...
    loading...
31
31 Cited Publications
Cat. No.: HY-101903
CAS No.: 300657-03-8
Purity:  99.93%
Target:  

FABP

BMS-309403 is a potent, orally active and selective adipocyte fatty acid binding protein (also known as FABP4, aP2) inhibitor with Kis of <2, 250, and 350 nM for FABP4, FABP3, and FABP5, respectively. BMS-309403 interacts with the fatty-acid-binding pocket within the interior of the protein and competitively inhibits the binding of endogenous fatty acids. BMS-309403 improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells .
loading...
    loading...
31
31 Cited Publications
Cat. No.: HY-101903A
CAS No.: 2802523-05-1
Purity:  99.93%
Target:  

FABP

BMS-309403 sodium is a potent, orally active, and selective adipocyte fatty acid binding protein (also known as FABP4, aP2) inhibitor, with Kis of <2, 250, and 350 nM for FABP4, FABP3, and FABP5, respectively. BMS-309403 sodium interacts with the fatty-acid-binding pocket within the interior of the protein and competitively inhibits the binding of endogenous fatty acids. BMS-309403 sodium improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells .
loading...
    loading...
29
29 Cited Publications
Cat. No.: HY-15870
CAS No.: 160162-42-5
Purity:  98.95%
Target:  

AP-1

Research Areas:  

Inflammation/Immunology Cancer

SR 11302 is an activator protein-1 (AP-1) transcription factor inhibitor. SR 11302 is a retinoid that specifically inhibits AP-1 activity without activating the transcription of retinoic acid response element (RARE) .
loading...
    loading...
26
26 Cited Publications
Cat. No.: HY-18777
CAS No.: 927822-86-4
Research Areas:  

Cancer

KC7F2 is a potent hypoxia inducible factor-1 (HIF-1) pathway inhibitor with an IC50 of 20 μM in LN229-HRE-AP cells, and with potential as a cancer therapy agent .
loading...
    loading...
18
18 Cited Publications
Cat. No.: HY-15858
CAS No.: 1177827-73-4
Purity:  99.87%
Synonyms: ENOblock
Target:  

Enolase Apoptosis

Research Areas:  

Metabolic Disease Cancer

AP-III-a4 (ENOblock) is a nonsubstrate analogue enolase inhibitor with an IC50 of 0.576 uM. AP-III-a4 can be used for the research of cancer and diabetic .
loading...
    loading...
18
18 Cited Publications
Cat. No.: HY-15858A
CAS No.: 2070014-95-6
Purity:  99.24%
Synonyms: ENOblock hydrochloride
Target:  

Enolase Apoptosis

Research Areas:  

Metabolic Disease Cancer

AP-III-a4 (ENOblock) hydrochloride is a nonsubstrate analogue enolase inhibitor with an IC50 of 0.576 uM. AP-III-a4 hydrochloride can be used for the research of cancer and diabetic .
loading...
    loading...
18
18 Cited Publications
Cat. No.: HY-B1272
CAS No.: 58-28-6
Desipramine hydrochloride is a first-generation tricyclic antidepressant. Desipramine hydrochloride selectively binds to norepinephrine transporter and blocks neuronal norepinephrine reuptake. Desipramine hydrochloride activates MAPK signaling via ERK1/2, JNK, and p38, represses NF-κB and AP-1 activity, and induces apoptosis via ROS elevation, mitochondrial membrane potential reduction, and intracellular calcium increase. Desipramine hydrochloride also shows anyi-inflammatory activity, inhibiting TNF-α production. Desipramine hydrochloride can be used for the research of hepatocellular cancer, inflammation, and neurological diseases .
loading...
    loading...
16
16 Cited Publications
Cat. No.: HY-19744
CAS No.: 2437475-16-4
Target:  

MyD88

Research Areas:  

Inflammation/Immunology

T6167923 is a selective inhibitor of MyD88-dependent signaling pathways. T6167923 directly binds to Toll/IL1 receptor (TIR) domain of MyD88 and disrupts MyD88 homodimeric formation. T6167923 inhibits NF-κB driven Staphylococcus enterotoxin AP (SEAP) activity, and improves anti-inflammatory activity with IC50s of 2.7 μM, 2.9 μM, 2.66 μM and 2.66 μM for IFN-γ, IL-1β, IL-6 and TNF-α, respectively .
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-13989
CAS No.: 1009817-63-3
Purity:  98.57%
Synonyms: NSC 687852
Research Areas:  

Cancer

b-AP15 is a specific inhibitor of the deubiquitinating enzymes UCHL5 and Usp14.
loading...
    loading...
14
14 Cited Publications
Cat. No.: HY-50908
CAS No.: 572924-54-0
Synonyms: MK-8669; Deforolimus; AP23573
Target:  

mTOR Autophagy Bacterial

Research Areas:  

Cancer

Ridaforolimus (MK-8669) is a potent and selective mTOR inhibitor; inhibits ribosomal protein S6 phosphorylation with an IC50 of 0.2 nM in HT-1080 cells .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-135815
CAS No.: 1847461-43-1
Purity:  99.60%
Synonyms: TAK-788; AP32788
Target:  

EGFR

Research Areas:  

Cancer

Mobocertinib (TAK-788) is an orally active and irreversible EGFR/HER2 inhibitor. Mobocertinib potently inhibits oncogenic variants containing activating EGFRex20ins mutations with selectivity over wild-type EGFR. Mobocertinib can be used in NSCLC research .
loading...
    loading...